Page last updated: 2024-10-30

mecamylamine and Carcinoma, Lewis Lung

mecamylamine has been researched along with Carcinoma, Lewis Lung in 2 studies

Mecamylamine: A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool.

Carcinoma, Lewis Lung: A carcinoma discovered by Dr. Margaret R. Lewis of the Wistar Institute in 1951. This tumor originated spontaneously as a carcinoma of the lung of a C57BL mouse. The tumor does not appear to be grossly hemorrhagic and the majority of the tumor tissue is a semifirm homogeneous mass. (From Cancer Chemother Rep 2 1972 Nov;(3)1:325) It is also called 3LL and LLC and is used as a transplantable malignancy.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Heeschen, C2
Weis, M1
Aicher, A1
Dimmeler, S1
Cooke, JP2
Zhu, BQ1
Sievers, RE1
Karliner, JS1
Parmley, WW1
Glantz, SA1

Other Studies

2 other studies available for mecamylamine and Carcinoma, Lewis Lung

ArticleYear
A novel angiogenic pathway mediated by non-neuronal nicotinic acetylcholine receptors.
    The Journal of clinical investigation, 2002, Volume: 110, Issue:4

    Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Carcinoma, Lewis Lung; Cell Division; Cells, Cultu

2002
Second hand smoke stimulates tumor angiogenesis and growth.
    Cancer cell, 2003, Volume: 4, Issue:3

    Topics: Animals; Carcinoma, Lewis Lung; Chemokine CCL2; Endothelial Cells; Hydroxymethylglutaryl CoA Reducta

2003